Trials / Completed
CompletedNCT00411515
A Prospective Randomized Trial on Mycophenolate Mofetil in Risk Penetrating Keratoplasty
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this prospectively randomized multicentre study was to prove the efficacy and safety of mycophenolate mofetil (MMF) to preventing graft rejection and improvement of clear graft survival following high-risk keratoplasty. The patients of the MMF group receive MMF orally 2x1 g daily for 6 months. Endpoints were immune reaction free and clear graft survival and the occurence of side-effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mycophenolate Mofetil 2x 1g |
Timeline
- First posted
- 2006-12-14
- Last updated
- 2006-12-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00411515. Inclusion in this directory is not an endorsement.